NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role. Over 30 animal studies have shown therapeutic effect in seven different indications. Phase Ib/II clinical trials in stroke and oncology demonstrated safety and evidence of efficacy, and the company is preparing to run a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF). *Cover photo painting by Diane Fairfield
Looking for a particular NuvOx Pharma employee's phone or email?
The NuvOx Pharma annual revenue was $11 million in 2026.
Jennifer Johnson is the COO of NuvOx Pharma.
8 people are employed at NuvOx Pharma.
NuvOx Pharma is based in Tucson, Arizona.
The NAICS codes for NuvOx Pharma are [32, 3254, 32541, 325].
The SIC codes for NuvOx Pharma are [283, 28].